摘要
目的 探讨蚓激酶治疗急性脑梗塞的临床疗效。方法 选择114例急性脑梗塞患者,随机分为治疗组(60例)与对照组(54例),治疗组应用蚓激酶加基础治疗,对照组应用复方丹参加基础治疗,疗程均为15天。结果 治疗组显效率为76.7％,对照组显效率为55.5％,两组差异非常显著(P<0.01);治疗组总有效率为95％,对照组总有效率为83.3％,两者差异显著(P<0.05);治疗组全血粘度、血浆粘度及纤堆蛋白原治疗前后差异非常显著(P<0.01),对照组治疗前后差异不显著(P>0.05)。结论 蚓激酶治疗急性脑梗塞疗效确切,无副作用,值得临床推广应用。
Objective To explore the clinical therapeutic effect of Yinjimei(YJM) in treating acute cerebral infarction (ACI). Methods 114 ACI patients who were chosed were randomly divided into the treated group(60patients) and the control group(54patients) .which were received YJM adding fundmental theraphy and Fu Fang Dan Shen adding fundmental theraphy respectively. The course of treatment lasted 15 days. Results The effective rate in the treated group and the control group was 76. 7% and 55. 5% respectively, with significant difference between the two groups(P<0. 01) ;The total effective rate in the two groups was 95% and 83. 3% respectively,with significant difference(P<0. 05) ;The treated group showed significant difference in levels of ηb·ηp and fibrinogen before and after treatment (P<0. 01), While the control group showed no significant difference(P>0. 05). Conclusion The treatment on ACI by TYM is effective, with no ineffection. It is worthy for further widely using on clinic.
出处
《青岛医药卫生》
2004年第6期408-409,共2页
Qingdao Medical Journal
